Logo image of AMK.CA

AMERICAN CREEK RESOURCES LTD (AMK.CA) Stock Fundamental Analysis

TSX-V:AMK - TSX Venture Exchange - CA0252883099 - Common Stock - Currency: CAD

0.09  0 (0%)

Fundamental Rating

2

Taking everything into account, AMK scores 2 out of 10 in our fundamental rating. AMK was compared to 802 industry peers in the Metals & Mining industry. The financial health of AMK is average, but there are quite some concerns on its profitability. AMK does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year AMK has reported negative net income.
In the past year AMK has reported a negative cash flow from operations.
In multiple years AMK reported negative net income over the last 5 years.
AMK had a negative operating cash flow in each of the past 5 years.
AMK.CA Yearly Net Income VS EBIT VS OCF VS FCFAMK.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -5M -10M

1.2 Ratios

Looking at the Return On Assets, with a value of -13.67%, AMK is in line with its industry, outperforming 53.87% of the companies in the same industry.
With a Return On Equity value of -14.24%, AMK perfoms like the industry average, outperforming 58.48% of the companies in the same industry.
Industry RankSector Rank
ROA -13.67%
ROE -14.24%
ROIC N/A
ROA(3y)14.68%
ROA(5y)5.59%
ROE(3y)14.88%
ROE(5y)5.55%
ROIC(3y)N/A
ROIC(5y)N/A
AMK.CA Yearly ROA, ROE, ROICAMK.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -200 -400 -600

1.3 Margins

AMK does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AMK.CA Yearly Profit, Operating, Gross MarginsAMK.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023

5

2. Health

2.1 Basic Checks

The number of shares outstanding for AMK remains at a similar level compared to 1 year ago.
The number of shares outstanding for AMK has been increased compared to 5 years ago.
AMK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
AMK.CA Yearly Shares OutstandingAMK.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M
AMK.CA Yearly Total Debt VS Total AssetsAMK.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M

2.2 Solvency

An Altman-Z score of 71.88 indicates that AMK is not in any danger for bankruptcy at the moment.
AMK's Altman-Z score of 71.88 is amongst the best of the industry. AMK outperforms 92.52% of its industry peers.
A Debt/Equity ratio of 0.04 indicates that AMK is not too dependend on debt financing.
AMK has a Debt to Equity ratio (0.04) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Altman-Z 71.88
ROIC/WACCN/A
WACCN/A
AMK.CA Yearly LT Debt VS Equity VS FCFAMK.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M 10M

2.3 Liquidity

AMK has a Current Ratio of 2.25. This indicates that AMK is financially healthy and has no problem in meeting its short term obligations.
With a Current ratio value of 2.25, AMK perfoms like the industry average, outperforming 57.86% of the companies in the same industry.
AMK has a Quick Ratio of 2.25. This indicates that AMK is financially healthy and has no problem in meeting its short term obligations.
AMK has a Quick ratio of 2.25. This is comparable to the rest of the industry: AMK outperforms 59.73% of its industry peers.
Industry RankSector Rank
Current Ratio 2.25
Quick Ratio 2.25
AMK.CA Yearly Current Assets VS Current LiabilitesAMK.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M

0

3. Growth

3.1 Past

AMK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -119.67%.
EPS 1Y (TTM)-119.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
AMK.CA Price Earnings VS Forward Price EarningsAMK.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AMK.CA Per share dataAMK.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.01 0.01 0.02

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

AMK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AMERICAN CREEK RESOURCES LTD

TSX-V:AMK (5/9/2025, 7:00:00 PM)

0.09

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)04-25 2025-04-25
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners1.01%
Ins Owner ChangeN/A
Market Cap40.45M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 5.67
P/tB 5.67
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS0.02
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -13.67%
ROE -14.24%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)14.68%
ROA(5y)5.59%
ROE(3y)14.88%
ROE(5y)5.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.25
Quick Ratio 2.25
Altman-Z 71.88
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-119.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-119.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-0.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-0.84%
OCF growth 3YN/A
OCF growth 5YN/A